Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GENB | PVLA | VCEL | ||
| Company | Generate Biomedicines Inc | Palvella Therapeutics Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.21 | 120.19 | 31.82 | ||
| High | 14.21 | 127.31 | 35.19 | ||
| Low | 12.99 | 115.34 | 31.28 | ||
| Latest | 13.75 | 123.46 | 34.14 | ||
| Change | +0.44 | +3.08 | +1.58 | ||
| % Change | +3.31% | +2.56% | +4.85% | ||
| Volume | 460,700 | 335,100 | 1,685,700 | ||
| 20-Day Average Volume | 503,580 | 291,950 | 823,045 | ||
| Previous Close | 13.31 | 120.38 | 32.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.36 | 123.09 | 32.33 | ||
| 20-Day Raw Stochastic | 85.16% | 42.21% | 83.11% | ||
| 20-Day Relative Strength | 55.15 | 54.95 | 51.19 | ||
| Weighted Alpha | N/A | +226.20 | -18.05 | ||
| Today's Opinion | N/A | 100% Buy | 72% Sell | ||
| Previous Opinion | N/A | 88% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.00% since 03/26/26 | +4.97% since 03/26/26 | +10.77% since 03/26/26 | ||
| Low | 11.11 on 03/27/26 | 108.63 on 03/30/26 | 28.95 on 03/27/26 | ||
| High | 14.21 on 04/02/26 | 133.05 on 03/31/26 | 35.19 on 04/02/26 | ||
| 1-Month | |||||
| %Chg | +12.98% since 03/02/26 | -6.90% since 03/02/26 | -3.45% since 03/02/26 | ||
| Low | 11.00 on 03/04/26 | 108.63 on 03/30/26 | 28.95 on 03/27/26 | ||
| High | 14.21 on 04/02/26 | 143.76 on 03/10/26 | 35.30 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | N/A since 02/27/26 | +23.12% since 01/02/26 | -4.13% since 01/02/26 | ||
| Low | 11.00 on 03/04/26 | 72.22 on 01/30/26 | 28.95 on 03/27/26 | ||
| High | 15.32 on 02/27/26 | 151.18 on 02/26/26 | 41.65 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/27/26 | +97.13% since 10/02/25 | +8.31% since 10/02/25 | ||
| Low | 11.00 on 03/04/26 | 61.73 on 10/03/25 | 28.95 on 03/27/26 | ||
| High | 15.32 on 02/27/26 | 151.18 on 02/26/26 | 43.00 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,752,437 | 1,767,206 | 1,738,818 | ||
| Shares Outstanding, K | 127,450 | 14,314 | 50,932 | ||
| Annual Sales | 31,893,000 | 0 | 276,260,000 | ||
| Annual Net Income | -203,154,000 | -17,430,000 | 16,520,000 | ||
| Last Quarter Sales | N/A | 0 | 92,920,000 | ||
| Last Quarter Net Income | N/A | -11,350,000 | 23,240,000 | ||
| 60-Month Beta | N/A | -0.21 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.08 on 03/31/26 | 0.45 on 02/26/26 | ||
| Latest Earnings Date | N/A | 05/21/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 105.03 | ||